New Hypofractionation Radiation Strategies for Glioblastoma.

about

New Hypofractionation Radiation Strategies for Glioblastoma.

Item

http://www.wikidata.org/entity/Q38666254

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

New Hypofractionation Radiation Strategies for Glioblastoma.

@en

type

Item

label

New Hypofractionation Radiation Strategies for Glioblastoma.

@en

prefLabel

New Hypofractionation Radiation Strategies for Glioblastoma.

@en

P1476

New Hypofractionation Radiation Strategies for Glioblastoma.

@en

P2093

Erqi Pollom

http://www.w3.org/2001/XMLSchema#string

Jennifer Shah

http://www.w3.org/2001/XMLSchema#string

Melissa Azoulay

http://www.w3.org/2001/XMLSchema#string

Scott G Soltys

http://www.w3.org/2001/XMLSchema#string

P2860

Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Immunologic correlates of the abscopal effect in a patient with melanoma

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

P2888

s11912-017-0616-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0616-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090866803

http://www.w3.org/2001/XMLSchema#string

P698

28735440

http://www.w3.org/2001/XMLSchema#string